ALLMedicine™ Pancreatic Cancer Center
Research & Reviews 14,181 results
https://doi.org/10.1016/j.canlet.2022.215863
Cancer Letters; Tian Z, Ou G et. al.
Aug 13th, 2022 - Perineural invasion (PNI) occurs in most pancreatic ductal adenocarcinomas (PDACs). The relationship between cancer cells and peripheral nerves, however, is unknown. Therefore, we focused on the cooperation of PDAC cells and peripheral nerve astro...
https://doi.org/10.1053/j.gastro.2022.07.080
Gastroenterology Rosenthal M, Schawkat K et. al.
Aug 13th, 2022 - A Growing Hope for Earlier Detection of Pancreatic Cancer.|2022|Rosenthal M,Schawkat K,Wolpin B,|
https://clinicaltrials.gov/ct2/show/NCT04083235
Aug 12th, 2022 - The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxaliplatin compared to nab-paclitaxe...
https://clinicaltrials.gov/ct2/show/NCT04239573
Aug 12th, 2022 - PRIMARY OBJECTIVES: I. To compare the rates of unfavorable clinical outcomes in the two arms. SECONDARY OBJECTIVES: I. To compare rates of major surgical morbidity and/or mortality between arms. II. To compare pancreatic cancer incidence and all-c...
https://clinicaltrials.gov/ct2/show/NCT03245541
Aug 12th, 2022 - The purpose of this study is to find out if combining durvalumab with standard stereotactic ablative radiotherapy (SABR) is an effective treatment for people with locally advanced or borderline resectable pancreatic cancer. The researchers will al...
Guidelines 27 results
https://doi.org/10.1016/j.gie.2021.12.001
Gastrointestinal Endoscopy; Sawhney MS, Calderwood AH et. al.
Feb 21st, 2022 - ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations.|2022|Sawhney MS,Calderwood AH,Thosani NC,Rebbeck TR,Wani S,|diagnosis,genetics,
https://doi.org/10.1016/j.gie.2021.12.002
Gastrointestinal Endoscopy; Calderwood AH, Sawhney MS et. al.
Feb 21st, 2022 - American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence.|2022|Calderwood AH,Sawhney MS,Thosani NC,Rebbeck TR,Wani S,|diagnosis,gene...
https://doi.org/10.1016/j.pan.2021.05.004
Pancreatology : Official Journal of the International Ass...
Jun 22nd, 2021 - Pancreatic cancer is the eighth most common cancer and the fifth most common cause of cancer-related death in Korea. To enable standardization of management and facilitate improvements in outcome, a total of 53 multi-disciplinary experts in gastro...
https://doi.org/10.6004/jnccn.2021.0017
Journal of the National Comprehensive Cancer Network : JN... Tempero MA, Malafa MP et. al.
Apr 13th, 2021 - Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058005
Clinical & Translational Oncology : Official Publication ... Gómez-España MA, Montes AF et. al.
Mar 5th, 2021 - Pancreatic cancer (PC) and biliary tract cancer (BTC) are both aggressive and highly fatal malignancies. Nowadays we have a profound knowledge about the molecular landscape of these neoplasms and this has allowed new therapeutic options. Surgery i...
Drugs 56 results see all →
Clinicaltrials.gov 2,139 results
https://clinicaltrials.gov/ct2/show/NCT04083235
Aug 12th, 2022 - The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxaliplatin compared to nab-paclitaxe...
https://clinicaltrials.gov/ct2/show/NCT04239573
Aug 12th, 2022 - PRIMARY OBJECTIVES: I. To compare the rates of unfavorable clinical outcomes in the two arms. SECONDARY OBJECTIVES: I. To compare rates of major surgical morbidity and/or mortality between arms. II. To compare pancreatic cancer incidence and all-c...
https://clinicaltrials.gov/ct2/show/NCT03245541
Aug 12th, 2022 - The purpose of this study is to find out if combining durvalumab with standard stereotactic ablative radiotherapy (SABR) is an effective treatment for people with locally advanced or borderline resectable pancreatic cancer. The researchers will al...
https://clinicaltrials.gov/ct2/show/NCT05438667
Aug 12th, 2022 - 1.This study is a single-arm, open-label, single-infusion clinical study. In this trial, 11 subjects with KRAS G12V or G12D mutations and matching HLA-A*11:01 subtypes are recruited for autologous Tumor-T Cell Receptor (TCR) -Mediated T Cells ther...
https://clinicaltrials.gov/ct2/show/NCT05111353
Aug 12th, 2022 - This is a randomized phase 1 clinical trial to evaluate the safety of an optimized neoantigen synthetic long peptide (SLP) vaccines in pancreatic cancer patients following neoadjuvant chemotherapy. The neoantigen SLP vaccines will incorporate prio...
News 1,316 results
https://www.mdedge.com/gihepnews/article/256922/gi-oncology/pancreatic-cancer-screening-new-onset-diabetes-appears-cost
Carolyn Crist, MDedge News
Aug 9th, 2022 - A risk-tailored early-detection strategy for pancreatic cancer that targets patients with new-onset diabetes could be cost effective, according to a recent study. Screening for pancreatic ductal adenocarcinoma in asymptomatic adults is not recomme.
https://www.medscape.com/viewarticle/978284
Aug 9th, 2022 - Guidelines on the diagnosis and treatment of dyspepsia were published in July 2022 by the British Society of Gastroenterology in Gut .[1] Selected strong recommendations are noted below. Functional dyspepsia is the underlying cause of symptoms in ...
https://www.medscape.com/viewarticle/978834
Aug 8th, 2022 - Fewer than one third of cancer patients pay out-of-pocket costs for genetic counseling services. But even among those who do, the cost is $16 or less, a cohort study shows. "The findings highlight the relatively low financial costs of genetic coun...
https://www.medscape.com/viewarticle/977581
Jul 20th, 2022 - Radiotherapy continues to be the odd man out in pancreatic cancer, according to Daniel Ahn, DO, and Tanios Bekaii-Saab, MD, medical oncologists at the Mayo Clinic in Phoenix, Arizona. "While perioperative chemotherapy has been shown to be an effec...
https://www.mdedge.com/gihepnews/article/256308/mixed-topics
Jul 15th, 2022 - Gastroenterology May 2022 Predicting Pancreatic Cancer in the UK Biobank Cohort Using Polygenic Risk Scores and Diabetes Mellitus Sharma S et al. Gastroenterology.